Patrick M. McDaneld

486 total citations
17 papers, 353 citations indexed

About

Patrick M. McDaneld is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Patrick M. McDaneld has authored 17 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Applied Microbiology and Biotechnology and 6 papers in Pharmacology. Recurrent topics in Patrick M. McDaneld's work include Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Patrick M. McDaneld is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Patrick M. McDaneld collaborates with scholars based in United States and Saudi Arabia. Patrick M. McDaneld's co-authors include Kady Phe, William L. Musick, Ming Hu, Jessica Cottreau, Nishant Prasad, Taijun Yin, Vincent H. Tam, Kenneth C. Lamp, Daryl D. DePestel and Elizabeth D. Hermsen and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Patrick M. McDaneld

16 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick M. McDaneld United States 9 186 179 123 106 61 17 353
John S. Esterly United States 13 218 1.2× 136 0.8× 133 1.1× 162 1.5× 56 0.9× 25 560
Syamhanin Adnan Australia 6 145 0.8× 247 1.4× 140 1.1× 153 1.4× 51 0.8× 6 383
Brent W. Gunderson United States 12 167 0.9× 185 1.0× 101 0.8× 51 0.5× 43 0.7× 15 455
Kady Phe United States 11 234 1.3× 268 1.5× 196 1.6× 107 1.0× 30 0.5× 17 400
Chi-Chang Huang Taiwan 9 208 1.1× 92 0.5× 161 1.3× 102 1.0× 29 0.5× 14 429
Angela Loo United States 10 151 0.8× 170 0.9× 151 1.2× 152 1.4× 141 2.3× 19 446
Satyajit Mohapatra India 6 273 1.5× 111 0.6× 135 1.1× 108 1.0× 68 1.1× 29 459
Daniel Eiras United States 9 143 0.8× 117 0.7× 113 0.9× 88 0.8× 48 0.8× 17 371
Jennifer Sekeres United States 5 244 1.3× 98 0.5× 194 1.6× 69 0.7× 42 0.7× 7 379
Matthew F. Wack United States 10 78 0.4× 204 1.1× 197 1.6× 82 0.8× 72 1.2× 15 443

Countries citing papers authored by Patrick M. McDaneld

Since Specialization
Citations

This map shows the geographic impact of Patrick M. McDaneld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. McDaneld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. McDaneld more than expected).

Fields of papers citing papers by Patrick M. McDaneld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick M. McDaneld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. McDaneld. The network helps show where Patrick M. McDaneld may publish in the future.

Co-authorship network of co-authors of Patrick M. McDaneld

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick M. McDaneld. A scholar is included among the top collaborators of Patrick M. McDaneld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick M. McDaneld. Patrick M. McDaneld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tverdek, Frank, Samuel L Aitken, Victor E. Mulanovich, et al.. (2024). Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infectious Diseases. 11(5). ofae235–ofae235. 1 indexed citations
2.
Shropshire, William C., Patrick M. McDaneld, Micah M. Bhatti, et al.. (2023). Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections. mSphere. 8(4). e0018323–e0018323. 3 indexed citations
3.
Shropshire, William C., Anna Konovalova, Patrick M. McDaneld, et al.. (2022). Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant Enterobacterales Bloodstream Infections. mSystems. 7(5). e0047622–e0047622. 21 indexed citations
4.
Eubank, Taryn A, et al.. (2021). Significant Publications on Infectious Diseases Pharmacotherapy in 2020. Journal of Pharmacy Practice. 36(2). 394–406. 1 indexed citations
5.
Robins, A. B., Emma Dishner, Patrick M. McDaneld, et al.. (2021). Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors. Supportive Care in Cancer. 30(2). 1643–1654.
6.
DiPippo, Adam J., Patrick M. McDaneld, Frank Tverdek, & Dimitrios P. Kontoyiannis. (2021). Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy. Antimicrobial Agents and Chemotherapy. 65(12). e0123021–e0123021. 4 indexed citations
7.
Gonzales-Luna, Anne J, et al.. (2020). Significant Publications on Infectious Diseases Pharmacotherapy in 2019. Journal of Pharmacy Practice. 34(5). 800–813. 2 indexed citations
8.
Gonzales-Luna, Anne J, Travis J Carlson, Natalie A. Finch, et al.. (2019). Significant Publications on Infectious Diseases Pharmacotherapy in 2018. Journal of Pharmacy Practice. 32(5). 546–557. 15 indexed citations
9.
Brown, Anne Rain, Terri Lynn Shigle, Jeffrey J. Tarrand, et al.. (2018). Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy. Antimicrobial Agents and Chemotherapy. 63(2). 24 indexed citations
10.
Phe, Kady, et al.. (2017). Significant Publications on Infectious Diseases Pharmacotherapy in 2016. Journal of Pharmacy Practice. 31(5). 469–480. 14 indexed citations
11.
McDaneld, Patrick M., et al.. (2014). Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists. Clinical Infectious Diseases. 59(suppl_3). S108–S111. 19 indexed citations
12.
DePestel, Daryl D., Edward H. Eiland, Katherine Lusardi, et al.. (2014). Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter. Clinical Infectious Diseases. 59(suppl_3). S154–S161. 38 indexed citations
13.
Burdette, Steven D., et al.. (2014). Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levels. American Journal of Health-System Pharmacy. 71(13). 1101–1107. 7 indexed citations
14.
Hermsen, Elizabeth D., Patrick M. McDaneld, Edward H. Eiland, et al.. (2014). Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool. Clinical Infectious Diseases. 59(suppl_3). S179–S184. 2 indexed citations
15.
Phe, Kady, Patrick M. McDaneld, Nishant Prasad, et al.. (2014). In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy. Antimicrobial Agents and Chemotherapy. 58(5). 2740–2746. 153 indexed citations
16.
McDaneld, Patrick M., Linda M. Spooner, John Mohr, & Paul Belliveau. (2013). Use of Daptomycin to Treat Infections With Methicillin-Resistant Staphylococcus aureus Isolates Having Vancomycin Minimum Inhibitory Concentrations of 1.5 to 2 µg/mL. Annals of Pharmacotherapy. 47(12). 1654–1665. 9 indexed citations
17.
Anderson, Peter L., Christina L. Aquilante, Edward M. Gardner, et al.. (2009). Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors. Journal of Antimicrobial Chemotherapy. 64(5). 1071–1079. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Esterly Breakdown of academic impact, for papers by Syamhanin Adnan Breakdown of academic impact, for papers by Brent W. Gunderson Breakdown of academic impact, for papers by Kady Phe Breakdown of academic impact, for papers by Chi-Chang Huang Breakdown of academic impact, for papers by Angela Loo Breakdown of academic impact, for papers by Satyajit Mohapatra Breakdown of academic impact, for papers by Daniel Eiras Breakdown of academic impact, for papers by Jennifer Sekeres Breakdown of academic impact, for papers by Matthew F. Wack
Rankless by CCL
2026